David Gallego-Ortega
Overview
Explore the profile of David Gallego-Ortega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salomon R, Razavi Bazaz S, Mutafopulos K, Gallego-Ortega D, Warkiani M, Weitz D, et al.
Lab Chip
. 2025 Jan;
25(5):1097-1127.
PMID: 39775440
Liquid biopsy provides a minimally invasive approach to characterise the molecular and phenotypic characteristics of a patient's individual tumour by detecting evidence of cancerous change in readily available body fluids,...
2.
Cassim A, Dun M, Gallego-Ortega D, Valdes-Mora F
Trends Cancer
. 2024 Sep;
10(12):1095-1105.
PMID: 39343635
The enhancer of zeste inhibitory protein (EZHIP) is typically expressed during germ cell development and has been classified as a cancer-testis antigen (CTA) in various cancers. In 2020, 4% of...
3.
Hjorth M, Egan C, Telles G, Pal M, Gallego-Ortega D, Fuller O, et al.
J Sport Health Sci
. 2024 Sep;
14:100991.
PMID: 39341495
Purpose: Regular exercise can reduce incidence and progression of breast cancer, but the mechanisms for such effects are not fully understood. The purpose of this study was to examine the...
4.
Colino-Sanguino Y, Rodriguez de la Fuente L, Gloss B, Law A, Handler K, Pajic M, et al.
Heliyon
. 2024 Sep;
10(17):e37185.
PMID: 39296129
Single-cell transcriptomics has emerged as the preferred tool to define cell identity through the analysis of gene expression signatures. However, there are limited studies that have comprehensively compared the performance...
5.
Salomon R, Razavi Bazaz S, Li W, Gallego-Ortega D, Jin D, Warkiani M
Micromachines (Basel)
. 2023 Jul;
14(4).
PMID: 37420984
This paper describes, in detail, a method that uses flow cytometry to quantitatively characterise the performance of continuous-flow microfluidic devices designed to separate particles. Whilst simple, this approach overcomes many...
6.
Kapellos T, Bassler K, Fujii W, Nalkurthi C, Schaar A, Bonaguro L, et al.
Cell Rep
. 2023 May;
42(6):112525.
PMID: 37243592
Systemic inflammation is established as part of late-stage severe lung disease, but molecular, functional, and phenotypic changes in peripheral immune cells in early disease stages remain ill defined. Chronic obstructive...
7.
Ganguly D, Schmidt M, Coleman M, Ngo T, Sorrelle N, Dominguez A, et al.
J Exp Med
. 2023 Feb;
220(5).
PMID: 36828390
Metastatic cancer cells adapt to thrive in secondary organs. To investigate metastatic adaptation, we performed transcriptomic analysis of metastatic and non-metastatic murine breast cancer cells. We found that pleiotrophin (PTN),...
8.
Yam A, Bailey J, Lin F, Jakovija A, Youlten S, Counoupas C, et al.
Cancer Res
. 2023 Feb;
83(8):1315-1328.
PMID: 36787115
Significance: Intratumoral injection of microbial bioparticles stimulates neutrophil antitumor functions, suggesting pathways for optimizing efficacy of microbial therapies and paving the way for their broader utilization in the clinic.
9.
Radfar P, Ding L, Rodriguez de la Fuente L, Aboulkheyr H, Gallego-Ortega D, Warkiani M
Biosens Bioelectron
. 2022 Dec;
223:114966.
PMID: 36580816
Effective isolation and in-depth analysis of Circulating Tumour Cells (CTCs) are greatly needed in diagnosis, prognosis and monitoring of the therapeutic response of cancer patients but have not been completely...
10.
Araujo A, Abaurrea A, Azcoaga P, Lopez-Velazco J, Manzano S, Rodriguez J, et al.
J Clin Invest
. 2022 Sep;
132(19).
PMID: 36169029
No abstract available.